Effect of different treatments on the abundance of gut microbiota in mice. (A) phylum level. (B) class level. (C) order level. (D) family level. (E) genus level. (F) species level. KFY3, KFY7, KFY11, KFY14: mice in KFY group on 3, 7, 11, and 14 days. DZP3, DZP7, DZP11, DZP14: mice in DZP group on 3, 7, 11, 14 days. *Uncultured.
Description
Correlation analysis between gut microbiota changes and neurotransmitter levels suggests that microbiome modulation by the probiotic-fermented grain complex may contribute to improved sleep-related outcomes.
Figure 7
ChartSource Paper
Protective effects of a probiotic-fermented germinated grain complex on neurotransmitters and sleep quality in sleep-deprived mice.Cite This Figure
 > Source: Jiahua Cheng et al. "Protective effects of a probiotic-fermented germinated grain complex on neurotra." *Frontiers in microbiology*, 2024. PMID: [39135872](https://pubmed.ncbi.nlm.nih.gov/39135872/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11317376/bin/fmicb-15-1438928-g007.jpg" alt="Correlation analysis between gut microbiota changes and neurotransmitter levels suggests that microbiome modulation by the probiotic-fermented grain complex may contribute to improved sleep-related outcomes." /> <figcaption>Figure 7. Correlation analysis between gut microbiota changes and neurotransmitter levels suggests that microbiome modulation by the probiotic-fermented grain complex may contribute to improved sleep-related outcomes.<br> Source: Jiahua Cheng et al. "Protective effects of a probiotic-fermented germinated grain complex on neurotra." <em>Frontiers in microbiology</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39135872/">39135872</a></figcaption> </figure>